A new dimension of the host-IAV arms race is revealed, centered on ACSL3 at the UPR crossroads. Key questions remain regarding ACSL3-UPR sensor interfaces and ACSL3 induction/degradation mechanisms.Addressing the questions will advance ACSL3-IAV interplay insights and may inform host-targeted therapy.
No takes yet. Share an insight, caveat, or question.
Mo et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: